Blood–brain barrier–transport artificial intelligence: A hybrid sequence–structure machine-learning framework for predicting blood–brain barrier-penetrant peptides
Brain Network Disorders · 2026-06
DOI: 10.1016/j.bnd.2026.04.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Network Disorders, 2026-06. Verfasst von Kartic und 3 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gachon University, Korea Ministry of Trade Industry and Energy.
Abstract (Originalsprache)
Background
Cell-penetrating peptides (CPPs) and blood–brain barrier (BBB) shuttles are promising vehicles for delivering therapeutics to the central nervous system; however, few BBB-permeable sequences have been experimentally validated. Existing prediction tools mainly rely on sequence motifs and rarely incorporate structural information or provide mechanistic insights. We present BBB–transport artificial intelligence (TransAI), a hybrid machine-learning pipeline that fuses classical peptide descriptors with structure-derived features from AlphaFold3 models to predict BBB permeability.
Methods
We collected a dataset of BBB + and BBB − peptides and extracted 10 best-performing families of sequence descriptors totaling 1133 features using iFeature. AlphaFold3-predicted three dimensional (3D) structures were used to compute the structural metrics for high confidence. Random Forest importance and correlation pruning reduced the sequence space to non-redundant descriptors, which were combined with the structural features for model training.
Results
The final Random Forest classifier achieved a receiver operating characteristic (ROC) area under the curve (AUC) of 0.73 on an independent test set; five-fold cross-validation yielded an increased mean ROC AUC of 0.81 ± 0.09. The feature importance highlighted hydrophobicity indices, polarizability scales, and secondary-structure propensities as key determinants. The structural analysis revealed that BBB-positive peptides exhibit a higher hydrophobic residue content, increased exposure of positively charged side chains, and intermediate compactness relative to negatives.
Conclusions
BBB-TransAI demonstrates that integrating AlphaFold3 structural descriptors with traditional sequence features enhances the prediction accuracy and yields mechanistic insights into BBB translocation. The framework is scalable to larger peptide libraries, can incorporate additional biophysical descriptors, and can be released as a Streamlit web server for the in silico screening of BBB shuttles. Our study also outlines the current limitations of annotation quality and structural uncertainty, and provides guidance for future community efforts in BBB peptide informatics.
Förderung
- Gachon University
- Korea Ministry of Trade Industry and Energy
Zitieren
APA
Kartic, Sharma, A., Yi, S., & Park, T. S. (2026). Blood–brain barrier–transport artificial intelligence: A hybrid sequence–structure machine-learning framework for predicting blood–brain barrier-penetrant peptides. Brain Network Disorders. https://doi.org/10.1016/j.bnd.2026.04.001
Vancouver
Kartic, Sharma A, Yi S, Park TS. Blood–brain barrier–transport artificial intelligence: A hybrid sequence–structure machine-learning framework for predicting blood–brain barrier-penetrant peptides. Brain Network Disorders. 2026. doi:10.1016/j.bnd.2026.04.001
BibTeX
@article{Kartic2026,
author = {Kartic and Sharma, Amitesh and Yi, Sanggyun and Park, Tae Sik},
title = {Blood–brain barrier–transport artificial intelligence: A hybrid sequence–structure machine-learning framework for predicting blood–brain barrier-penetrant peptides},
journal = {Brain Network Disorders},
year = {2026},
doi = {10.1016/j.bnd.2026.04.001}
}
EUVIMED